DG
Dhau Gangaram Lambore
About Dhau Gangaram Lambore
Data last updated:
Dhau Gangaram Lambore is a Director at Polson Ltd (since 2008), Director at Oriental Pharmaceutical Industries Limited (since 2014) and Director at The New Commercial Mills Company Limited (since 2014), and holds 3 more current directorships. The companies operate in Chemicals and Materials, Financial Services and Metals and Minerals. The 4 current companies with reported revenue have a combined latest revenue of ₹96.93 Cr; the largest is Polson Ltd at ₹95.14 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 May 2008 | 1938 | ₹95.14 Cr (FY 2025) | Active | |
| Director | 13 Feb 2014 | 1941 | ₹1.75 Cr (FY 2024) | Active | |
| Director | 13 Feb 2014 | 1952 | ₹3.7 Lakh (FY 2024) | Active | |
| Director | 13 Feb 2014 | 1943 | ₹1.7 Lakh (FY 2017) | Active | |
| Partner | 31 Mar 2015 | 2014 | Active | ||
| Director | 02 Dec 2010 | 2010 | Active |
Board colleagues of Dhau Gangaram Lambore
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alka Shashikant Dhuri | 10657583 | Polson Ltd | Director |
| Amol Jagdish Kapadia | 01462032 | Polson Ltd , Oriental Pharmaceutical Industries Limited and 4 more | Managing Director |
| Bhavin Suryakant Sheth | 00114608 | Polson Ltd | Director |
| Rajiv Ghanshyamdas Agarwal | 00518199 | Polson Ltd | Director |
| Sampada Sachin Sawant | Polson Ltd | Company Secretary | |
| Sanjay Shantaram Bhalerao | Polson Ltd | Cfo | |
| Youhaan Amol Kapadia | 09509180 | Polson Ltd , Oriental Pharmaceutical Industries Limited and 2 more | Director |
| Sushila Jagdish Kapadia | 02105539 | Coriander Homes Limited Liability Partnership | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dhau Gangaram Lambore
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhau Gangaram Lambore
Dhau Gangaram Lambore currently holds 6 directorships: Polson Ltd (Director, since 12 May 2008, revenue ₹95.14 Cr (FY 2025)); Oriental Pharmaceutical Industries Limited (Director, since 13 Feb 2014, revenue ₹1.75 Cr (FY 2024)); The New Commercial Mills Company Limited (Director, since 13 Feb 2014, revenue ₹3.7 Lakh (FY 2024)); New Commercial Investment And Trading Co Ltd (Director, since 13 Feb 2014, revenue ₹1.7 Lakh (FY 2017)); Coriander Homes Limited Liability Partnership (Partner, since 31 Mar 2015); and 1 more.
Dhau Gangaram Lambore was first appointed on 12 May 2008 as Director at Polson Ltd. The most recent appointment on record is 31 Mar 2015 at Coriander Homes Limited Liability Partnership.
The 4 current companies of Dhau Gangaram Lambore that report revenue have a combined latest revenue of ₹96.93 Cr: Polson Ltd ₹95.14 Cr (FY 2025); Oriental Pharmaceutical Industries Limited ₹1.75 Cr (FY 2024); The New Commercial Mills Company Limited ₹3.7 Lakh (FY 2024); New Commercial Investment And Trading Co Ltd ₹1.7 Lakh (FY 2017).
The current boards of Dhau Gangaram Lambore's companies include Alka Shashikant Dhuri (Polson Ltd), Amol Jagdish Kapadia (Polson Ltd), Bhavin Suryakant Sheth (Polson Ltd), Rajiv Ghanshyamdas Agarwal (Polson Ltd), Sampada Sachin Sawant (Polson Ltd), Sanjay Shantaram Bhalerao (Polson Ltd), among others.